CXCL1 and acute-on-chronic liver failure: As an example, a recent study on HBV-related acute-on-chronic liver failure (ACLF) found that another CXC chemokine, which was CXCL1, predicted 28-day mortality almost as well as MELD (AUC 0.74 vs. 0.75) [69].